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Summary Rheumatoid arthritis (RA) is an autoimmune disease of unknown etiology and is
mainly characterized by the progressive erosion of cartilage leading to chronic polyarthritis
and joint distortion. Although the exact pathogenesis of the disease has yet not been
elucidated, however, studies suggest that cellular proliferation of synoviocytes result in pannus
formation which damages the cartilage and bone. Recent reports also support the role of free
radicals in its pathogenesis. Apart from the conventional treatment strategies using nonsteroidal
anti-inflammatory drugs, disease modifying antirheumatic drugs and glucocorticoids, newer
and safer drugs are continuously being searched, as long term usage of these drugs have
resulted in adverse effects. Alternative medicine provides another approach for treatment of
RA and currently a number of medicinal plants are under scientific evaluation to develop a
novel drug. There is a dire need to investigate the complete therapeutic potential and adverse
effects, if any, of these herbals for providing newer and safer treatment options with minimum
side effects. In this review we have tried to explore various Indian ancient Ayurvedic, Unani
and Tibbi, as also some Chinese and Korean, herbals for their potential to treat RA.
Key Words: rheumatoid arthritis, alternative medicine, Indian herbal, free radical, cytokine
*To whom correspondence should be addressed.
Tel: +91-9415007706    Fax: +91-522-2257540
E-mail: mahdiaa@rediffmail.com
Brijesh Rathore is a Senior Research Fellow at the Department of Bio-
chemistry, King George’s Medical University, Lucknow, India. He is
postgraduate in Applied Biochemistry, and is engaged in the cytokine
and free radical research; and their implication in rheumatoid arthritis.
Abbas Ali Mahdi is Professor in Department of Biochemistry,
King George’s Medical University, Lucknow, India. He is engaged
in the free radical research in different human diseases such as
Rheumatoid arthritis, Alzheimer’s, Male infertility and Anemia.
Published more than 77 research papers in peer reviewed journals.
Bhola Nath Paul is a Senior Scientist at Industrial Toxicology Research
Centre, Lucknow, India. His areas of research are Cytokines, allergy and
asthma. He has published 45 research papers in peer reviewed journals.
Prabhu Narayan Saxena is Professor in Department of Zoology, Dr.
B.R. Ambedkar University, Agra, India. His main research interest
includes Cybil related reproductive and hepatobiochemical changes.
Published more than 50 research articles in peer reviewed journals.
Siddharth Kumar Das is Head of the Rheumatology Department,
King George’s University, Lucknow, India. Research interests include
treatment of osteoarthritis and RA. He is founder of Rheumatology
Department at K.G. Medical University. Published over 50
research papers in peer reviewed journals.Indian Herbals for Rheumatoid Arthritis
Vol. 41, No. 1, 2007
13
Introduction
Rheumatoid arthritis (RA) is a systemic inflammatory
disorder which mainly affects the diarthrodial joint. It has
societal effect in terms of cost, disability, and lost productivity.
However the pathogenesis of disease is not well understood.
Efforts are being made to understand the cellular and molecular
mechanism for the pathogenesis of RA. It has been reported
that proinflammatory cytokines such as tumor necrosis
factor-α (TNF-α), interleukin (IL)-1β, and IL-6 are important
mediators of the disease perpetuation. Moreover, there are
also reports that free radical generation worsens the disease
and contribute towards damage to bone and cartilage.
Immune cells such as T cells also impart their role in the
progress of the disease. Apart from the conventional
treatment strategies using nonsteroidal anti-inflammatory
drugs (NSAIDs), disease modifying antirheumatic drugs
(DMARDs) and glucocorticoids newer and safer drugs
are continuously being searched, as long term usage of
these drugs have resulted in the hepatic and gastrointestinal
disorders. Alternative medicine is another therapeutic
approach for treatment of the disease, which include herbal
and folklore medicines. Many plants and plant products are
under scientific exploration to develop a novel therapeutic
agent. Here we have tried to review mainly various Indian
ancient Ayurvedic, Unani and Tibbi, as also some Chinese
and Korean, medicinal plants for their potential to treat RA.
Rheumatoid Arthritis: An Immunological Insight
RA is a chronic, autoimmune and systemic inflammatory
disease which targets synovial joints [1]. Its prevalence is
estimated at 2.5–3% in the adults above 50 years of age.
Despite significant gains in knowledge of the immuno-
pathology, the exact etiology of RA remains uncertain [2].
The genetic basis for RA is rather complex. It has been
reported that RA does not aggregate in families with very
high frequency [3]. In addition, the concordance rates in
identical (monozygotic) twins are relatively low (12–15%)
[4]. However, human leukocyte antigen (HLA) association
supports the hypothesis that genetic factors are important for
susceptibility to RA.
Joint damage occurs very early in RA [5]. Among the
prominent symptoms pain, joint swelling, stiffness, deformity
and weight loss are common, while palpation tenderness,
synovial thickening, erythema, warmth and decreased mobility
are the articular characteristics. An inflamed synovium is
central to the pathophysiology of RA. The synovial tissue of
patients with RA is characterised by mononuclear cell
infiltration, neovascularisation and proliferation of synovial
fibroblasts [6]. Synovial vessel endothelial cells transform into
high endothelial venules early in the course of the disease. The
formation of locally invasive tissue ‘pannus’ takes place,
which is an important characteristic feature of rheumatoid
joint. This ‘pannus’ consists of mononuclear cells and
fibroblasts with the expression of matrixmetalloproteinases,
which later on turns into fibrous pannus comprising of
vascularised layer [7]. It has been speculated that perpetuation
of inflammation is associated with the production of pro-
inflammatory cytokines [8]. Inflammatory cytokines are
essential mediators in the pathogenesis of RA. IL-1β and
TNF-α are the principal mediators of tissue destruction in
RA. These two cytokines induce, in synergy, the production
of high levels of matrixmetalloproteinases by synovial cells
and chondrocytes [9].
Association of Free Radicals with RA
In recent years, there are growing evidences of possible
role of highly reactive products of oxygen and nitrogen
termed as free radicals [10], in the pathogenesis of RA as
well as other degenerative diseases [11, 12]. These reactive
oxygen species (ROS) and reactive nitrogen species (RNS)
are produced endogenously during aerobic metabolism and
at the site of chronic inflammation. ROS such as super oxide
radical, hydroxyl radical and hypochlorous acid contribute
significantly to tissue injury in RA [13]. Several mechanisms
are involved in the generation and action of ROS in the joint
of RA patient, including increased pressure in synovium
cavity, reduced capillary density, vascular changes and
increased metabolic rate of synovial tissue. In addition
activated leukocytes also produce ROS [14]. Super oxide
radical and hydrogen peroxide do not directly damage the
majority of biomolecules, they are converted into the highly
reactive hydroxyl radicals, which reacts with almost all
molecules in living cells. ROS can directly or indirectly
damage basic articular constituents and lead to the clinical
expression of the inflammatory arthritis [15]. Synovial cavity
damage correlation with fluctuating oxygen pressure in the
joint, overproduction of ROS, lack of oxygen-processing
enzymes and free radical-scavenging molecules have been
reported in RA [16]. RA patients have an increased plasma
conjugated dienes and significantly decreased vitamins E
and A levels, which increases oxidative stress and damages
tissue [17, 18]. Moreover, there is growing evidence that
oxidative stress exacerbates inflammation and worsens joint
tissue [19].
Normal equilibrium between ROS production and anti-
oxidant system of the cell is disturbed due to oxidative
stress, thus resulting in the damage to vital cell components
such as proteins, DNA and membrane lipids. There are
number of reports depicting that ROS plays a major role in
the inflammation and related diseases. There are several
studies demonstrating increased levels of malondialdehyde
in the RA patients [20]. Significant decrease in the activities
of catalase has also been reported in RA patients. Similarly,B. Rathore et al.
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glutathione reductase activities also get disturbed in the
synovial fluid of patients [21]. Moreover, the levels of
thioredoxine, which is a marker of oxidative stress, are
significantly higher in synovial fluid of RA patients.
Findings of McInnes et al. 1996, reveals that production of
nitric oxide (NO) is upregulated in arthritic tissue [22].
Treatment Strategies
In the past decade, there has been a transformation in the
treatment of RA in terms of approach and choice of drugs too.
Previous treatment strategies involved initial management
by NSAIDs for several years. NSAIDs have represented an
effective therapy for treating RA by eliciting their effects
by inhibiting cyclooxygenase activity and blocking the
downstream production of prostanoids and eicosonoids. The
advantages of early management of rheumatoid arthritis
with DMARDs were not well recognized, until recently,
and treatment options were limited to mono- or combination
therapy with a relatively restricted therapeutic armament.
DMARD therapy showed decrease in the markers of
inflammation such as erythrocyte sedimentation rate and
swollen joint counts. The combination therapy comprises
immunosuppressives and DMARDs. This may exacerbate
the potential for hepatic enzyme disturbances. Additional
side-effects include weight loss, diarrhea, skin rash and
alopecia [23].
Although the recent years have brought new information
for the researchers and clinicians, but the treatment of RA
still remains a challenge. Cytokine research has led to idea
for the use of anti-cytokine therapy for the treatment of RA.
Etanercept (recombinant form of the p75 TNFR-II) and
Infliximab (monoclonal antibody directed against TNF-α)
were the first biological response modifiers approved for
the treatment of RA in the year 1992 [24, 25]. Both drugs
have been designed to bind with TNF-α and decrease its
bioavailability. Apart from all the above described treatment
approaches scientists are now trying to cure RA using gene
therapy, but it is still not fully explored.
Alternative Approach
Because of the limitations and risks of conventional
therapy, people are exploring alternative measures to treat
the disease. Commonly used alternative approaches include
dietary modifications, nutritional supplements and botanicals.
The response to these treatments varies from patient to
patient. Alternative treatments have been used both as
adjunct and an alternative to conventional therapy. Most of
the treatments are relatively free of side effects [26].
Herbal Therapies
Herbal medicine provides a foundation for various
traditional medicine systems worldwide. Today, these herbs
contribute approximately 25% of currently used crude drugs
and another 25% is derived from chemically altered natural
products [27]. Herbal therapies occupy a large section of
alternative therapy. India, along with its wealth, is rich in
wide variety of medicinal plants, a large number of popular
remedies many of which are in common use even today.
More than 2000 plants of medicinal value are mentioned
in Indian ancient Ayurvedic, Unani and Tibbi systems of
medicine [28]. We have also carried out a number of studies
on possible intervention of herbal preparations with diabetic
and arthritic conditions in experimental animals [29, 30].
Ginger (Zinziber officinalis, Zinziberacea) has been used
for centuries in Indian ayurvedic medicine and traditional
medicine system as an anti-inflammatory agent. It is cultivated
all over tropic and subtropical Asia and 50% of the world’s
harvest is produced in India. Five constituents of ginger
have been identified as inhibitors of prostaglandins. Another
constituent of ginger, gingerol inhibited lipopolysaccharide
(LPS) induced inducible nitric oxide synthase (iNOS)
expression and production of NO in vitro [31]. According
to a study, oral administration of ginger oil suppressed the
induction of adjuvant induced inflammation [32].
Similarly, Pineapple has also been used as a medicinal
plant after its recognition in late 18th century. Bromelain, an
extract of pineapple stem, has been reported to possess
anti-inflammatory property. It is a general name for a family
of sulfhydryl proteolytic enzymes obtained from Ananas
comosus, the pineapple plant. Active components of bromelain
are peroxidase, acid phosphatase, several protease inhibitors.
When bromelain was tried with RA patients, 72% of total
patients reported reduced swelling and pain [33].
Turmeric (Curcuma longa), is commonly used in Chinese
and Indian (Ayurvedic) medicine system, possess curcumin
which is an active anti-inflammatory component. It is a
perennial plant, grows 3 to 5 feet high in the tropical regions
of Southern Asia. The rhizome, the root, of curcuma is
used in medicinal and food preparations. Curcumin is the
main active component of this herb, and exhibits antioxidant
properties. Significant improvement in morning stiffness,
walking time and joint swelling have been observed as anti-
arthritic effects after regular curcuma consumption by RA
patients [34].
Harshingar (Nyctanthes arbor tristis Linn., NAT) has
been used widely as a decoction for the treatment of arthritis
and sciatica in Indian ayurvedic system of medicine since
centuries. The plant has its origin from the Bengal region of
India while it is distributed all over sub tropical regions of
country. Arbortristosides, nyctanthic acid, and crocetin are the
main active principals of NAT. Water soluble ethanolic extractIndian Herbals for Rheumatoid Arthritis
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of NAT leaves have been reported to reduce significantly
the levels of inflammatory cytokines (IL-1, TNF-α) in
experimental arthritis [35].
Chirayita (Swertia Chirayita), a herb found abundantly in
the temperate regions of Himalaya, is commonly used for
chronic fever, anemia and asthma. The plant inhabitats the
pastures and slopes of the Himalayas and rages upto the
height of 3,000 metres. Chirayita comprises of swerchirin,
swertanone and swertianin, as active components respon-
sible for the anti-inflammatory activity. Chirayita is reported
to reduce the elevated levels of IL-1β, TNF-α and IL-6 (Pro-
inflammatory cytokines) in experimental arthritis as well as
in asthmatic conditions [36].
Saffron (Crocus sativus, Iridaceae) is commonly used as
folk medicine for various purposes such as aphrodisiac,
antispasmodic and expectorant. It is a perennial flowering
plant with very less growing height upto 40 cm. Commonly
cultivated in the Kashmir and ranges to Northern America,
Greece and Spain. Saffron stigma possesses anti-inflammatory
action due to presence of crocetin and carotenoids. Aqueous
and ethanolic extracts of saffron petals exhibit radical
scavenging as well as anti-inflammatory effects in xylene
and formalin induced inflammation [37].
Karvi (Strobilanthus callosus, Acanthaceae), another
Indian medicinal herb, commonly found in the Maharastra
state has been used by the local tribals for the treatment of
inflammatory disorders. The Lupeol and 19α-H Lupeol
isolated from the roots of Strobilanthus callosus have
demonstrated the anti-inflammatory as well as anti-rheumatic
activity in carrageenan induced oedema [38].
Trewia polycarpa Benth (Euphorbiaceae) roots are also
used in Indian Ayurvedic medicine for the treatment of
rheumatism, arthritis and gastritis [39]. Two Indian species
viz.  Trewia nudiflora Linn. and Trewia polycarpa Benth
are common. No toxicity has been observed after oral
administration of alcoholic extract at different dose to wistar
rats, also superoxide dismutase, glutathione peroxidase
activities were found to be elevated thus indicating the free
radical scavenging property [40].
Madimadi, a Korean folk medicine, is a kind of fermented
alcohol prepared from water extracts of herbal medicines. It
has also been used for the treatment of RA since long
time by the natives of the Korea. Madimadi had inhibitory
effects on pro-inflammatory cytokine, and dose dependently
inhibited TNF-α, IL-1β and IL-8 production in RA patients.
Madimadi also downregulates the TNF-α and IL-1β [41].
Among the Chinese traditional medicine system,
‘Thunder God Vine’ (Tripterygium wilfordii Hook F, TwHF)
occupies the foremost place for the treatment of autoimmune
and inflammatory diseases such as RA, systemic lupus
erythematosus, psoriasis etc. It is a perennial vine like plant
growing in southern China and Taiwan. Triptolide is the
main active component which imparts the anti-inflammatory
and free radical scavenging potential. Dose dependent studies
of ethyl acetate extract of TwHF roots have in symptomatic
improvement in 50% of RA cases during the first 4 weeks of
treatment. Suppression of adhesion molecules like E-
selectin, intracellular adhesion molecule-1 (ICAM-1) and
vascular cell adhesion molecule-1 (VCAM-1) contribute
for the anti-inflammatory action of the TwHF extract [42].
Inhibition of iNOS expression by TwHF extract downregulates
nuclear factor-kappa B (NF-κB) DNA binding activity and
results in the ROS scavenging [43].
Another Chinese folk medicine Shiraia bambusicola has
long been utilized in the treatment of RA. The active
component of Shiraia bambusicola, Shiraiachrome A,
significantly inhibits the proliferation, migration, and
angiogenesis by blocking growth factor-stimulated auto-
phosphorylation of receptor tyrosine kinases in diseased
synovium [44]. Another Chinese herbal medicine Qin Jiao
(Gentiana macrophylla, Gentianaceae) is also reported to be
used in the treatment of diabetes, paralysis and rheumatism.
It has been reported that roots of Gentiana have anti-
inflammatory effect in RA patients, which is quite comparable
to Prednisone, a conventional drug used to treat RA [45].
Conclusions
RA is a debilitating disease usually manifesting as
inflammation of multiple joints. Severity of the disease
ranges from minor pain to joint deformity. While the cause
of the disease is still not known completely, the treatment
includes the NSAIDs and DMARDs. However, the biologic
response modifiers are available in the market but still under
critical examination for their effects in RA patients. With
increasing awareness, a large section of RA patients have
started adopting the alternate therapeutic measures. There is
a need for screening and scientifically evaluating number of
known ancient Indian Ayurvedic and Unani medicinal plants
for providing newer and safer treatment options with
minimum side effects.
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